Skip to content
pirenzepine

Structure via PubChem · Public domain (PubChem)

EntityQ419550· pop 16· linked from 723 articles

pirenzepine

Sign in to save

Also known as PIR335, 11-[(4-methyl-1-piperazinyl)acetyl]-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one

Pirenzepine (Gastrozepin), an M1 selective antagonist, is used in the treatment of peptic ulcers, as it reduces gastric acid secretion and reduces muscle spasm. It is in a class of drugs known as muscarinic receptor antagonists; acetylcholine is the neurotransmitter of the parasympathetic nervous system which initiates the rest-and-digest state (as opposed to fight-or-flight), resulting in an increase in gastric motility and digestion; whereas pirenzepine would inhibit these actions and cause decreased gastric motility leading to delayed gastric emptying and constipation. It has no effects on

Chemical data

Formula
C19H21N5O2
Molecular weight
351.4 g/mol
IUPAC name
11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
SMILES
CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4
InChIKey
RMHMFHUVIITRHF-UHFFFAOYSA-N
XLogP
0.1
Polar surface area
68.8 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Small molecule
Admin. routes
oral
Indications
Peptic ulcer, gastroesophageal reflux disease, peripheral neuropathy, gastric ulcer

via ChEMBL · EBI

Research

5,229 papers

via PubMed

Wikidata facts

Mass
351.169525
Has use
medication
Show 7 more facts
subject has role
muscarinic antagonist
chemical formula
C₁₉H₂₁N₅O₂
Commons category
Pirenzepine
canonical SMILES
CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4
World Health Organisation international non-proprietary name
pirenzepine
has characteristic
bitterness
defined daily dose
20
Sources (5)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • See also
  • References

Pirenzepine (Gastrozepin), an M1 selective antagonist, is used in the treatment of peptic ulcers, as it reduces gastric acid secretion and reduces muscle spasm. It is in a class of drugs known as muscarinic receptor antagonists; acetylcholine is the neurotransmitter of the parasympathetic nervous system which initiates the rest-and-digest state (as opposed to fight-or-flight), resulting in an increase in gastric motility and digestion; whereas pirenzepine would inhibit these actions and cause decreased gastric motility leading to delayed gastric emptying and constipation. It has no effects on the brain and spinal cord as it cannot diffuse through the blood–brain barrier.

Pirenzepine has been investigated for use in myopia control.

Excerpted from Wikipedia’s “pirenzepine” article, available under the CC BY-SA 4.0 licence.